Exposing Pump and Dumps - All my own opinions / not financial advice
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The drug, according to the FDA, failed twice, which is why they are not doing CD16 / CD17 in the US. Not sure why you're saying it works. Spare me the "BP/FDA corruption" Alex Jones nonsense too. They failed their primary end points. First 14 days that they tout as P < 0.02 is dumb bc as I have shown Day 14-28 means with stat sig it kills more than SoC. And spare me the half life nonsense bc the patients had plenty left.
Given away now or fire sold in bankruptcy? May as well give it to CYDY shareholders like Rolando and Dr Nicolas to pump it!!! Remember the mob always pays its henchmen very well (Fife, Nicholas, Recknor, see lawsuits about self-enrichment).... Today is nothing more than a paid pump, probably by Fife, as he continues to unload shares on baggies. The Fife Partitions don't work if there is no volume.
Remind me, how much did Nader say he was charging Chiral Pharma Corporation for vials under CSP? Did he give a price? I know he said he could "sell or charge" for it under CSP. Does anyone know?
Fife wins as long as retail baggies continue to keep volume up. He can partition notes and blast out of the stock over a week or two making annualized 100% returns. It is a joke
If they do, they will make sure the gov't, or related parties, profit from it, not the chop shop Chiral Pharma Corporation...
Another Day Another Fifing
By my calculation, after being 12% of the volume yday, he needs to sell ~1mm more shares, which should take him another 3-5 days at this rate
Then he gets to partition ANOTHER $7.5mm from one of his senior secured notes, bc we know CYDY can't pay him cash so they meeenneemmalll deeluuttteee bagholders. That probably happens in two weeks so maybe you get a week of reprieve before more selling? YIKES
How'd that 4/21 prediction work out?
As for volume isn't it scary how Fife's Partitions overlap with large VWAP/AH trades and he's getting more aggressive in terms of % of volume?
Date PX_LAST Volume % of Vol VWAP/AH
4/26/2021 $3.17 1,412,916 12.00% 151,389
4/23/2021 $3.21 1,638,881 15.10% 215,000
4/22/2021 $3.28 1,919,431 19.72% 316,117
4/21/2021 $3.24 1,498,480 20.63% 256,236
4/20/2021 $3.33 1,500,298 0.00% -
4/19/2021 $3.50 2,344,263 0.00% 27
4/16/2021 $3.28 2,653,471 0.31% 8,132
4/15/2021 $3.05 5,020,763 15.05% 656,821
4/14/2021 $2.85 5,357,210 15.15% 704,725
4/13/2021 $2.99 2,254,835 15.11% 295,998
4/12/2021 $3.11 2,489,382 14.61% 317,322
4/9/2021 $3.13 3,606,090 8.06% 268,942
4/8/2021 $3.09 6,124,564 0.01% 400
4/7/2021 $3.50 5,849,584 0.05% 2,794
4/6/2021 $3.94 4,876,752 0.14% 7,000
4/5/2021 $3.98 9,628,223 1.62% 153,534
4/1/2021 $3.19 3,222,118 0.40% 12,938
3/31/2021 $2.70 4,507,243 3.93% 170,363
3/30/2021 $2.82 10,878,614 12.17% 1,180,538
The funds are being used to pay promoters, fund lawsuits, pay their salaries, pay trial sites, and most importantly to pay back other Fife notes. Remember Fife gets at a minimum $28.5mm within a year for a $25mm investment. Usually it comes in the form of stock which he then punts immediately after. Also, remember, in bankruptcy he gets paid first, then the pref note holders, then the common. The common will be completely worthless when volume dries up and they can no longer partition the Fife Notes bc he won't be able to sell them in the open market without crushing the stock.
Fife not playing games
After the most recent partition and the drop in volume, I wouldn't be shocked if Fife were 30% of today's volume. He has another 1.25mm shares to sell and has no reason to hold them. The next partition probably happens next week so he needs to dump these shares before he has another 2-3mm shares to dump next week
Ok, I'll concede that point but then explain why CD12 trial was an abject failure then (No EUA, no partnerships, nothing but it seems like FDA shutting it down CD16/CD17)?
Pualson / Fife selling has been 20% of the volume the past three days.
With every partition comes another 2 to 2.5mm shares for Fife to sell.
As I calculate it, Fife is earning about 65% return on his notes, which annualize to be about 92% via the OID (remember 28.5mm is what they owe fife and only get $25mm) and partitioning the notes.
Fife has made btwn $200k and $2.5mm by punting the 1.8 to 3.6mm shares immediately after getting them on 1/29, 3/12, and 4/8. He selling another chunk now. I wonder what that will net him? I wonder what selling 2-3mm shares every two weeks does to the stock? Yikes
You realize that in the 8K the SAEs were actually the same for the LL arm as the SoC right? The whole premise of "no SAEs" is a big fallacy. The only thing the bulls could hang their hat on in the CD10 trial was SAE reduction!!! No look at CD12 SAEs... ugh oh
Why did Nader say the aren't doing CD16/CD17 in the US? Did the FDA shut them down for COVID?
You understand these interviews are done by doctors who own / were given stock in Cytodyn. It’s in their financial interest to pump the living crap out of this failed drug company
It is more facts that this mgmt team is completely and utterly corrupt, pushing a drug that does nothing (failed CD10/CD12), pays promoters to fool you bagholders (remember Philippines guys like Rolando and Randy all own stock), promotes henchmen like Reckor, pushed out people like Mahboob, Pestell, etc, and sells stock whenever they possibly can.
Breeze, was this your Big PR for 4/21? Seems like the settlement didn't go as planned?
Does nobody care that Vice Chancellor Paul Fioravanti rejected Cytodyn's settlement?
Or are we bagholders simply overlooking the fact that this is the SECOND time Nader is in court for unjust enrichment? It seems that Nader is going to have to give back 100% of his stock and option rewards. He is going to be very angry
it was put out to inform shareholders as a requirement for something
Exactly! That they will need to rerun trials for HIV. How this is not an 8K'able event is beyond me. Then again, this pump and dump didn't 8K CD10 failure so who knows what else they are hiding
Breeze, where is the 4/21 PR you promised?
Cytodyn snuk in a very important piece of info in this release
Ask yourself...Why would this professional pump and dump company (all heavy PRs periods coincide with particions and Fife dumping) issue a corporate presentation without a PR when they will literally PR the same nonsense from 12m prior in hopes to drive up the share price?
Answer: They buried something. You have to have a discerning eye but pay attention
They cannot market or sell the drug without FDA approval so the PR, which was done six months ago, is literally pointless and worth about as much as a Nader “In My Opinion the stock should be triplet digits.” Cacophony
BP buyout for a company that has a dozen lawsuits, a drug that failed two COVID trials, toxic debt, criminals as Mgmt caught lying dozens of times, paid promoters, and no revenue in sight. You’re right tho someone will definitely buy this company out of bankruptcy for about $5mm EV
Not enough to offset the $10mm they lost from a “bad batch” courtesy of Mahboob
Any long holders hanging around the hoop for an “epic shortiez squeeze” is going to be sorely disappointed. The only squeeze that’s going to happen are the cuffs
squeezing ever so tight on Nadder and Kelly’s dainty wrists
Fife will keep partitioning the notes and continue to dilute the bagholders for as long as the baggies continue to let him do it. He's currently in the middle of dumping stock from the most recent partition (hence the pumps).
Just for some context
The Jan 2019 $5mm note netted him >$35mm from conversions, plus legal settlement of 4mm on June 29th (remember that jump and dump?)
The July $25mm note with $10 convert has already netted hum $30mm in eight months and CYDY still owes him $7.9mm. If they paid him right now, that would be a 65% return or 92% annualized.
FIFE IS BLEEDING THIS COMPANY DRY
Why are you so convicted in 4/21? BTW good call on 10Q today
If it will never get approval in the US what makes you think that other countries will approve it?
Most countries require the country in which you are domiciled to approve the drug
Wrong! CD12 trial results (last page) shows SAEs for LL same as SoC
Leronlimab SAE = SoC SAEs
They straight up failed CD10. they still have not released these data
CD12 failed almost every endpoint and if one adjusted for alpha and multiplicity they failed everything
The first 14 day PR is nonsense. I have posted about the following 14 days, which has a p-value of 0.1 that you are 2.5x more likely to die from LL than SoC. Remember the first 14 days was 2 deaths vs 5 deaths, drawing any conclusions from that small of a hand-picked sample set is moronic
2 and 5 actually LOL. I broke it down
https://twitter.com/GooglePumpDump/status/1376917569341427718?s=20
Leronlimab 2.5x higher fatality rate than SOC in 2nd 14 days
If you break out the math from their 8k and the most recent PR it shows, with almost statsig, that during the 2nd 14 day period for critical patients, Leronlimab makes you 2.5x more likely to die than standard of care! Crazy data mining!
https://twitter.com/GooglePumpDump/status/1376917569341427718?s=20
1 friggin patient OMG.
Anyone know where the Fife S-3 is?
The S-3 is almost a full month late with another $7.5mm payment due any day.
What happens if nothing is approved this year?
Where do they get the money to pay for trials, lawsuits, Samsung, Fife, and operations? Isn't this an automatic bankruptcy in the next 6 months if they don't get an approval for something?
$100 is a 40x from here, but that assumes they don't continue to dilute the crap out of you like they are doing. 100% shares outstanding growth annually is pretty amazing. So more like you need an 80x from here fully diluted
$0 comes from a missed payment from Fife, Samsung, etc. They failed all COVID trials and still don't have one approved indication...
Where are they going to get the money for another trial
They are out of cash!
"These results were not stat significant, but they are still the best results"
This is baggie gold. They failed CD10 and CD12. The FDA doesn't "shut you down" unless the treatment HARMS the patient. Few understand this but it is critical
It’s cute the retail investors holding the pump and dump bag calls anyone “sophomoric”
$500mm valuation is INSANE.
The HIV product, if approved, is MAYBE worth $50mm to a partner (that market is very small and already many approved drugs). There’s no way Cytoshit could build out a sales team to sell this snake oil HIV drug vs other players so they’d have to sell it or watch it be a commercial flop.
The NASH/TNBC/etc are just dumb pipe dreams that cost a ton of money to run trials, that they don’t have, and are worth zero. Most pipe dreams are valued at zero in biotech.
The COVID therapeutic indication we see today is worth zero
The long haulers is a joke. It failed all covid trials but it’ll work for long haulers? LOL! Also, there’s some actual nefarious activity happening, per the FDA, by these trial doctors who are advertising results while also leading the trial sites (FDA may fine Gaylis and Reckor and could pull trial sites).
So what are you left with?
$50mm HIV drug that still needs to submit BLA by YE, $75mm total payable to Samsung, and lord knows how much they owe Fife + Fife lawsuits (last lawsuit netted him $22.5mm in stock), then there’s carrying costs / operation expenses. All in this is most likely a BK in the next 6-12m. With fife crushing the stock with his ratchet before then
Price Target of $0.15. I’ll likely cover around there
Covid is done
Pre-covid this company had an EV of $50mm
There will be 700mm shares outstanding shortly
50/700 = 0.07
However they have a huge payable to Samsung, for a worthless covid drug that will never sell, and they owe Fife lots of cash so this will end in bankruptcy but the last 1% is always the most difficult shorting.
You know that data mining for a subgroup subpopulation is illegal right? If you give me a trial of 395 placebo vs placebo I can find something stat sig esp if I hide the said data outside of a p-value.
Nothing outside of failing the primary (0/1) and secondaries (0/4) matters to the FDA.
If Nader and Co want to run ANOTHER trial, which will cost money that don’t hVe, and fail like CD10 and CD12, they can easily do so.
If Loserlimab were anything other than saline, they would have hit one primary in CD10 or CD12; however, they didn’t.
The FDA knows it doesn’t work (that doesn’t mean they will stop them from running trials bc it is indeed “safe”), BP knows so they will never partner, institutions know so they will never invest, other countries rely on the FDA to rule on a domestic company’s drug before making a decision (see Philippines), and the toxic lenders know this so they prey on the company (Fife’s lawsuits + ratchets will net him hundreds of millions).
Shares outstanding have gone from 300mm to 610mm the past 16 months. More dilution is coming and BK WILL FOLLOW
This is the most egregious public market fraud I have ever seen in my 15yrs of shorting. Three insanely misleading PRs in ten minutes. Subgroup subpopulation cherry picked regressions. S-3. Self enrichment judgements. Philippines, Mexico, Canada, FDA, EUA, etc, etc. known criminals running trials (Chris Reckor). Doxxing the head of the FDA. They aren’t even trying to hide it anymore. Nader and Co are thumbing their noses at the SEC and FDA. This won’t end well.